v3.25.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of RSU and RSA Activity
The following table summarizes the RSU and RSA activity for the three months ended March 31, 2025:
Number of Class A SharesWeighted-
Average
Grant Date
Fair Value
(in thousands, except per share data)
Unvested at December 31, 2024134,253$11.90 
Granted32,030$10.77 
Vested(23,360)$11.93 
Forfeited(7,654)$11.20 
Unvested at March 31, 2025135,269$11.66 
Schedule of Stock Option Award Activity
The following table summarizes the stock option award activity for the three months ended March 31, 2025:
Number of
Class A Shares		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value (1)
(in thousands, except per share data)
Outstanding at December 31, 2024680$16.01 4.51$253 
Granted—$— —— 
Exercised—$— —— 
Forfeited(15)$13.33 —— 
Outstanding at March 31, 2025665$16.07 3.97$133 
(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our Class A common stock as of March 31, 2025 and December 31, 2024.
Schedule of Total Stock-based Compensation Expense
Total stock-based compensation expense by function was as follows:
Three Months Ended March 31,
20252024
(in thousands)
Cost of revenue$1,434 $1,815 
Research and development156,688 174,519 
Sales and marketing54,440 54,656 
General and administrative34,776 32,762 
Total$247,338 $263,752